Rexulti and Remeron drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Rexulti and Remeron together. This study is created by eHealthMe based on reports of 48 people who take Rexulti and Remeron from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on brexpiprazole and mirtazapine (the active ingredients of Rexulti and Remeron, respectively), and Rexulti and Remeron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Rexulti?

Rexulti has active ingredients of brexpiprazole. (latest outcomes from Rexulti 5,311 users)

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Remeron 20,035 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 15, 2019

48 people who take Rexulti, Remeron are studied.


Number of reports submitted per year:

Rexulti and Remeron drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Therapeutic response unexpected
  2. Localised oedema (fluid retention in a particular part of the body)
  3. Oedema peripheral (superficial swelling)
  4. Adverse reaction
  5. Chills (felling of cold)
  6. Dizziness
  7. Drug effect decreased
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Feeling cold
1 - 6 months:
  1. Ligament sprain (ligament stretched)
  2. Pulmonary embolism (blockage of the main artery of the lung)
6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Eye disorder
  2. Irritability
  3. Jaw disorder (jaw disease)
  4. Laryngitis (inflammation of the larynx)
  5. Ligament sprain (ligament stretched)
  6. Localised oedema (fluid retention in a particular part of the body)
  7. Loss of consciousness
  8. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  9. Mood swings (an extreme or rapid change in mood)
  10. Muscle twitching

Most common drug interactions by gender *:

female:
  1. Drug ineffective
  2. Restlessness (not able to rest)
  3. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  4. Fall
  5. Headache (pain in head)
  6. Ligament sprain (ligament stretched)
  7. Nausea (feeling of having an urge to vomit)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Tinea infection (fungal skin infection)
male:
  1. Restlessness (not able to rest)
  2. Weight increased
  3. Disturbance in attention
  4. Drug ineffective
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Sleep-related eating disorder (abnormal eating patterns during the night)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Activities of daily living impaired
  9. Affective disorder (mental disorder)
  10. Akathisia (a movement disorder characterized by a feeling of inner restlessness)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Aggression
  2. Irritability
  3. Mood swings (an extreme or rapid change in mood)
  4. Negative thoughts
  5. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  6. Self-injurious ideation
  7. Therapeutic response unexpected
20-29:
  1. Fall
  2. Head discomfort
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  7. Vomiting
30-39:
  1. Ligament sprain (ligament stretched)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Drug ineffective
40-49:
  1. Dental caries
  2. Disturbance in attention
  3. Drug ineffective
  4. Oral infection
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Sleep-related eating disorder (abnormal eating patterns during the night)
  7. Weight increased
  8. Arthropathy
  9. Bladder cancer
  10. Bladder cancer stage iv
50-59:
  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Laryngitis (inflammation of the larynx)
  3. Loss of consciousness
  4. Neuropathy peripheral (surface nerve damage)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Vomiting
  8. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  9. Tinea infection (fungal skin infection)
  10. Localised oedema (fluid retention in a particular part of the body)
60+:
  1. Restlessness (not able to rest)
  2. Drug ineffective

* Approximation only. Some reports may have incomplete information.


Do you take Rexulti and Remeron?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Rexulti and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Remeron and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Rexulti and Remeron
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Rexulti and Remeron (7,853 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.